US Broker Ratings

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 45% Potential Upside

Fair Isaac Corporation (NYSE: FICO), a stalwart in the technology sector with a focus on software applications, offers a compelling investment narrative for those seeking growth opportunities. With a market..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 117.88% Potential Upside in the Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a prominent player in the medical devices sector, is capturing investor attention with a remarkable potential upside of 117.88%. Despite its current challenges, the company’s..

Candel Therapeutics, Inc. (CADL) Stock Analysis: Unlocking a 226% Potential Upside in Biotechnology

Candel Therapeutics, Inc. (NASDAQ: CADL), a standout player in the biotechnology sector, presents an intriguing opportunity for investors with its impressive potential upside. With a market capitalization of $313.47 million,..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Evaluating the 112.66% Potential Upside

Investors with an eye for potential growth opportunities in the biotech sector may find Compass Therapeutics, Inc. (NASDAQ: CMPX) a compelling option, especially given the impressive 112.66% potential upside indicated..

Spok Holdings, Inc. (SPOK) Stock Analysis: Navigating a 55% Potential Upside in Healthcare Communication

Investors looking for opportunities in the healthcare sector may want to take a closer look at Spok Holdings, Inc. (NASDAQ: SPOK), a unique player in the health information services industry...

NetClass Technology Inc (NTCL): Navigating Challenges in the Software Application Sector

For investors keeping an eye on small-cap technology stocks, NetClass Technology Inc (NTCL) presents a unique narrative within China’s burgeoning software application industry. Headquartered in Shanghai and incorporated in 2022,..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating the Upsurge in Revenue Growth

AMTD Digital Inc. (HKD), a multifaceted player in the technology sector, has caught the eye of investors with its staggering revenue growth of 1,085.90%. Despite operating in a competitive space..

Sprout Social, Inc. (SPT) Stock Analysis: Unlocking a Potential 98.76% Upside in the Social Media Software Space

In the ever-evolving landscape of technology, Sprout Social, Inc. (NASDAQ: SPT) stands out as a noteworthy player in the software application industry. Headquartered in Chicago, Illinois, Sprout Social specializes in..

Nyxoah SA (NYXH) Stock Analysis: A 137% Potential Upside in the Healthcare Sector

For investors seeking to capitalize on growth opportunities in the healthcare sector, Nyxoah SA (NASDAQ: NYXH) presents a compelling case. Specializing in medical instruments and supplies, this Belgium-based company is..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Exploring 74% Potential Upside in the Biotech Sector

In the dynamic and ever-evolving biotechnology sector, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) stands out as a clinical-stage biopharmaceutical company, focused on advancing therapies for women’s cancers. With a market capitalization..

Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 78.57% Potential Upside in the Healthcare Data Sector

Health Catalyst, Inc. (NASDAQ: HCAT), a key player in the healthcare information services sector, is garnering attention from investors with its substantial potential upside of 78.57%. Headquartered in South Jordan,..

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 27% Upside Potential

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector, specializes in the design, manufacture, and sale of X-ray imaging components. With a market capitalization of $583.94 million,..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Unveiling a 60% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. Known for its innovative respiratory care solutions, Viemed is making..

Nano-X Imaging Ltd (NNOX): Investor Outlook on a Promising Healthcare Disruptor with 205% Upside Potential

Nano-X Imaging Ltd (NNOX), a pioneering company in the medical devices sector, is making waves with its innovative approach to tomographic imaging. Headquartered in Petah Tikva, Israel, Nano-X is on..

Immutep Limited (IMMP) Stock Analysis: Exploring a 251.85% Potential Upside in Biotech Breakthroughs

Immutep Limited (NASDAQ: IMMP) stands out as a significant player in the biotechnology sector with its innovative approach to cancer and autoimmune disease therapies. Based in Sydney, Australia, the company..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Promising 66% Upside Potential in Biotech Innovation

For investors eyeing the biotech sector, Entrada Therapeutics, Inc. (NASDAQ: TRDA) presents a compelling opportunity. With a market capitalization of $413.53 million, this Boston-based clinical-stage biopharmaceutical company is making strides..

Quantum-Si Incorporated (QSI) Stock Analysis: Unveiling a 160% Potential Upside in the Medical Device Sector

Quantum-Si Incorporated (NASDAQ: QSI), a trailblazer in the healthcare sector with a focus on medical devices, is making waves with its cutting-edge technology in Next Generation Protein Sequencing (NGPS). Headquartered..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS), a pioneering player in the healthcare sector, has captured the attention of investors with its innovative approach to diabetes management. Specializing in the development of continuous..

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Challenges with Global Reach in Rapid Diagnostics

Anbio Biotechnology (NNNN), a burgeoning player in the healthcare sector, stands at the intersection of innovation and market volatility. With a current market capitalization of $1.01 billion, this German company..

Cidara Therapeutics (CDTX) Investor Outlook: Navigating the Biotech Frontier with Minimal Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is a biotech firm that stands at the cutting edge of healthcare innovation, focusing on targeted therapies for serious diseases, including challenging fungal infections and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds